EPHA2 Antibody

Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand- independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.

9007-83-4

Western blot: 1:1000

P29317

Human

This EPHA2 antibody was produced from a rabbit immunized with a KLH conjugated synthetic peptide between 518-552 amino acids from the central region of human EPHA2.

WB, ELISA

Antigen affinity

Antigen affinity purified

In 1X PBS, pH 7.4, with 0.09% sodium azide

Aliquot the EPHA2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

This EPHA2 antibody is available for research use only.

Aliquot the EPHA2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

In 1X PBS, pH 7.4, with 0.09% sodium azide

Titration of the EPHA2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Primate